Organigram Global (OGI) Income from Discontinued Operations (2025)
Organigram Global (OGI) posted quarterly Income from Discontinued Operations of 5378147.12 for Q4 2025.
Organigram Global (OGI) Income from Discontinued Operations (2025) Analysis & Trends
Organigram Global (OGI) has reported Income from Discontinued Operations for 1 consecutive years, with 5378147.12 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Organigram Global | 152.05 Mn | 151.93 Mn | 28.97 Mn | 13.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.38 Mn |